ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s share price traded down 5.2% on Tuesday . The stock traded as low as $9.01 and last traded at $9.37. 925,646 shares were traded during trading, a decline of 69% from the average session volume of 3,018,049 shares. The stock had previously closed at $9.88.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group upped their target price on shares of ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a research note on Wednesday, May 21st.
Read Our Latest Stock Report on ASP Isotopes
ASP Isotopes Trading Up 8.4%
The company has a 50 day moving average of $8.03 and a 200 day moving average of $6.16. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.21 and a quick ratio of 7.17.
Institutional Investors Weigh In On ASP Isotopes
Institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets bought a new position in ASP Isotopes during the 4th quarter valued at about $34,000. SBI Securities Co. Ltd. increased its holdings in shares of ASP Isotopes by 84.8% during the first quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock worth $44,000 after buying an additional 4,299 shares in the last quarter. Avantax Advisory Services Inc. bought a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $45,000. Russell Investments Group Ltd. boosted its holdings in shares of ASP Isotopes by 56.3% in the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after acquiring an additional 3,682 shares in the last quarter. Finally, Covestor Ltd bought a new stake in ASP Isotopes during the 4th quarter worth approximately $54,000. Institutional investors and hedge funds own 16.80% of the company's stock.
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
